Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07324200 · ClinicalTrials.gov registry record
Objective Assessment of Intraocular Lens Tilt and Decentration
A clinical trial of Tilt and Decentration, sponsored by Johnson & Johnson Surgical Vision.
- Recruiting
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT07324200: Recruiting study of Tilt and Decentration, sponsored by Johnson & Johnson Surgical Vision.
NCT07324200 is a study of Tilt and Decentration that is actively recruiting participants, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 80 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07324200, a study of Tilt and Decentration, is actively recruiting participants, sponsored by Johnson & Johnson Surgical Vision.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, multi-center, non-interventional, open label, randomized clinical study.
Primary Outcome
The primary endpoints for this study will be: * Magnitude of IOL decentration relative to the visual axis through OCT (IOL Master 700) image analysis. * Direction of IOL decentration relative to the visual axis through OCT (IOL Master 700) image analysis. * Magnitude of IOL tilt relative to the visual axis through OCT (IOL Master 700) image analysis. * Direction of IOL tilt relative to the visual axis through OCT (IOL Master 700) image analysis.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST OCT Imaging Test
Study Locations (2)
California
- Empire Eye & Laser Center - Bakersfield
Iowa
- Jones Eye Center - Sioux City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2026-04-24 |
What NCT07324200 shows while recruiting
NCT07324200 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 1 condition, with Tilt and Decentration appearing as the primary indexed condition, and to 1 intervention - of which OCT Imaging Test is the first listed.
NCT07324200 reports a single indexed study location in California, Iowa.
Frequently Asked Questions
What is clinical trial NCT07324200 about?
NCT07324200 is a clinical study titled "Objective Assessment of Intraocular Lens Tilt and Decentration". Prospective, multi-center, non-interventional, open label, randomized clinical study.
What is the current status of trial NCT07324200?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2026-03-03. Estimated completion is 2026-04-24.
What conditions does trial NCT07324200 study?
This clinical trial studies the following conditions: Tilt and Decentration.
What interventions are being tested in trial NCT07324200?
The interventions under investigation include: OCT Imaging Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07324200?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07324200 being conducted?
This trial has 2 study locations across California, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tilt and Decentration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI